Equine herpesvirus-1 is a highly prevalent and frequently pathogenic infection of equids. The most serious clinical consequences of infection are abortion and equine herpesvirus myeloencephalopathy (EHM). In recent years, there has been an apparent increase in the incidence of EHM in North America, with serious consequences for horses and the horse industry. This consensus statement draws together current knowledge in the areas of pathogenesis, strain variation, epidemiology, diagnostic testing, vaccination, outbreak prevention and control, and treatment.
Publication Type
- Other Publications
Topic
- Equine Herpesvirus (EHV)
- Horses
Publish Date
March 18, 2024
Related Guidelines
Position on the Use of Medroxyprogesterone Acetate in Competition Horses
Medroxyprogesterone acetate (MPA) is a synthetic progestin hormone administered to mares off-label…
Position on the Use of Horses in Urban Environments
The AAEP supports the use of horses and other equids in urban…
Position on the Use of Therapeutic Medication in the Racehorse
The AAEP policy on medication in pari-mutuel racing is driven by our…